enVVeno Medical Corporation stock is up 49.42% since 30 days ago. The next earnings date is Apr 29, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 5 March’s closed higher than February. In the last 2 Unusual Options Trades, there were 2 CALLs.
enVVeno Medical Corporation focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the. treatment of severe deep venous chronic venous insufficiency.
Unlock Exclusive Market Insights! Receive timely updates on market developments. Sign up & stay informed!